RXO, Inc. Form 8-K Summary
Business Context and Reporting Period
RXO, Inc. filed a Form 8-K dated May 3, 2023, reporting quarterly results for the fiscal quarter ended March 31, 2023. The filing announces the release of a results press release and investor presentation as Exhibits 99.1 and 99.2.
Financial and Operating Metrics
The provided filing text does not include the quarterly revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics. Those details are contained in the referenced press release and investor presentation, which are not included in the source text.
Material Changes Versus the Prior Comparable Period
The filing text does not provide a clear comparison with the prior-year or prior-quarter period.
Capital Allocation, Outlook, and Risks
- On May 2, 2023, the board authorized a share repurchase program for up to $125 million of common stock.
- The program authorizes an indeterminate number of shares, has no expiration date, and may be suspended or discontinued at any time.
- RXO is not obligated to repurchase any specific number of shares.
- The filing text does not provide guidance, detailed management commentary, contingencies, or unusual items.
Key Facts to Verify
- Quarterly revenue, operating income, net income, adjusted EBITDA, diluted earnings per share, and year-over-year changes in the Exhibit 99.1 press release.
- Cash flow, debt, liquidity, and balance-sheet information in the Form 10-Q for the quarter ended March 31, 2023.
- Management’s outlook, market assumptions, and risk factors in the investor presentation and Form 10-Q.
- Actual share repurchases and remaining authorization under the $125 million program.